Zacks boosts Surgery Partners shares: 4 things to know

Zacks upgraded Nashville, Tenn.-based Surgery Partners shares from a “hold” to a “buy” rating, according to Petro Global News.

Advertisement

Here are four things to know:

1. Zacks’ price target on Surgery Partners shares totals $21.

2. On March 10, 2017, Stifel Nicolaus lowered the company’s rating from a “buy” to a “hold.”

3. Surgery Partners has a one-year low of $11.76 and one-year high of $22.85.

4. The market cap is $967.64 million.

More articles on surgery centers:
SurgCenter Development opens 13th center in Florida; Envision Q4 EBITDA totals $208.7M & more – 6 ASC company notes
4 legislative changes for ASC leaders to note
Banner Health: Tucson ASC, other projects will offset financial setbacks

Advertisement

Next Up in ASC Transactions & Valuation Issues

  • Outpatient care remains one of healthcare’s hottest investment targets in 2026. From new multimillion-dollar ASC builds to joint venture partnerships,…

  • Tenet’s ASC arm, United Surgical Partners International, is positioning itself for a new growth runway as Medicare begins phasing out…

  • Certificate-of-need laws remain one of the biggest regulatory forces shaping where and how ASCs can grow, and the landscape is…

Advertisement

Comments are closed.